|
FOR
IMMEDIATE RELEASE
September
15, 2004.
Genetix has
launched a new hybrid bed option designed to compliment its medium-throughput,
fully featured QArray2 microarray platform.
Increased Operational Flexibility for Microarrayer
Genetix
has launched a new hybrid bed option designed to compliment its
medium-throughput, fully featured QArray2 microarray platform.

The
new hybrid bed option allows the flexibility to array either into
16 microtitre plates or onto 32 conventional glass slides on the
same instrument. This unique bed design can hold either a standard
SBS dimension microplate or 2 standard slides within a single destination
footprint, allowing the flexibility to array onto both these formats
on a single platform.
The
new hybrid bed option was launched in response to the increasing
interest in printing DNA or protein arrays into 96- or 384-well
microplates, especially for application areas such as drug screening
and clinical sample testing. This format has certain advantages
over arraying onto slides in terms of ease of automation of the
downstream array processing, higher-throughput parallel analysis
of samples, in addition to savings in terms of cost and time.
CONTACTS:
|
Worldwide
HQ
Genetix
Limited
Queensway
New Milton
UK
Tel:
+ 44 1425 624600
Email: info@genetix.com
www.genetix.com
|
North
America HQ
Genetix
USA Inc.
Boston, MA
tel.
1-877-436-3849
|
German
HQ
Genetix
GmbH
Dornach, Nr Munchen
Tel:
49-89 944 90 275
|
|